Where is the science in Scientific Advice?
This event has expired
Are your investors urging you to seek Scientific Advice? Are you uncertain if you’re ready to apply for a CTA? Truly Labs and Arex Advisor will discuss how bringing together scientific and regulatory strategies can increase your chances for a positive and successful Scientific Advice strategy.
Three Takeaways
- The science – how can new drug projects be evaluated, and what data package is required.
- The plan – the importance of strategic planning for scientific and regulatory success.
- The value - options for scientific advice to ensure efficient use of resources.
Speakers
- Anna Ravnefjord, Senior Expert at Arex Advisor.
- Erik Hedner, Director of Drug Development at Arex Advisor.
- Karin von Wachenfeldt, CEO of Truly Labs.
- Charlott Brunmark, CSO of Truly Labs.
About
Truly Labs AB – full service preclinical CRO. Expertice in multiple drug modalities and therapeutic areas. Experimental and strategic support to preclinical development.
Arex Advisor AB – expertise in RA, QA, pharmacovigilance and market access. We are committed to the development process leading to submission and commercialization of new treatments.